Ultomiris Rapidly Eases Symptoms of Generalized MG in Phase 3 Trial
Treatment with Ultomiris (ravulizumab-cwvz), a complement-blocking therapy, quickly eased symptom severity in adults with generalized myasthenia gravis (gMG), according…
Articles by Marisa Wexler, MS
FDA Approves Vyvgart for Adults With Most Common Form of gMG
Vyvgart (efgartigimod) has been approved by the U.S. Food and Drug Administration (FDA) to treat adults with generalized myasthenia gravis…
‘Human-on-a-Chip’ Disease Model Can Potentially Test Therapies Better
“Human-on-a-chip” technology developed by Hesperos can be used to model myasthenia gravis (MG), a new study shows. “This…
Zai Lab Plans to Seek Efgartigimod Approval in China in Early 2022
Zai Lab is planning — in the first half of 2022 — to ask Chinese authorities to approve…
Price of Soliris Far Too High, as Efgartigimod’s Likely Will Be: ICER
The Institute for Clinical and Economic Review (ICER), an independent nonprofit that evaluates the prices and benefits of medications in…
Efgartigimod Better Than Placebo at Easing gMG Symptoms: ADAPT Trial
More adults with generalized myasthenia gravis (gMG) who were treated with efgartigimod in a Phase 3 trial experienced minimal…
Robot-assisted Thymectomy Helps Man Get Back Outdoors
Robot-assisted thymectomy surgery — a procedure to remove the thymus gland, here done using a robotic system console —…
1st Patient Dosed in Phase 3 Trial of Batoclimab in China
The first participant has been dosed in a Phase 3 clinical trial testing the efficacy and safety of batoclimab (HBM9161)…
Swallowing Muscle Test May Help Diagnose MG
The flexible endoscopic evaluation of swallowing-tensilon test (FTT), a new diagnostic tool for myasthenia gravis (MG), can be used…
CAR T-cell Therapy Descartes-08 Eased MG Symptoms
Treatment with Descartes-08, an investigational CAR T-cell therapy, markedly eased symptoms of myasthenia gravis (MG) in three patients participating…